• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Truveta Tru, a research assistant powered by generative AI, now in Truveta Studio

Truveta Tru, a research assistant powered by generative AI, now in Truveta Studio

by Truveta News | Oct 28, 2024 | News

We are excited to share our latest AI innovation – Truveta Tru, Truveta Studio’s research assistant powered by generative AI. Trained on the Truveta Language Model (TLM) and Truveta Data, Tru enables researchers to accelerate their research in Truveta Studio using...
Healthcare AI: Earning trust and adoption by the research community

Healthcare AI: Earning trust and adoption by the research community

by Jay Nanduri | Oct 28, 2024 | Technology

In the journey toward advancing healthcare research, trust in AI tools is essential. Truveta is committed to not only delivering powerful AI-driven data insights but also ensuring transparency, quality, and speed for researchers. A significant part of this commitment...
Truveta Symposium brings together healthcare, public health, and life science organizations with a shared mission of Saving Lives with Data

Truveta Symposium brings together healthcare, public health, and life science organizations with a shared mission of Saving Lives with Data

by Truveta staff | Jul 9, 2024 | News

Today, Truveta kicks off Truveta Symposium, a unique event bringing together leaders from health systems, life sciences, and the government to collaborate on health research with real-world data, embracing generative AI to transform healthcare, and improving patient...

Share this


Recent posts

  • How Truveta benchmarks AI model quality for clinical concept extraction
  • Truveta Data analysis shows improved outcomes with Impella support in high-risk heart procedures
  • Evaluating recent trends in early measles vaccinations in Texas

Follow Truveta


Sign up for our newsletter

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice